Newborn Screening Market worth $1.3 billion by 2026- Leading Key Players are PerkinElmer (US), Demant A/S (Denmark), Natus Medical (US), Bio-Rad Laboratories (US), Danaher Corporation (US), and Medtronic (Ireland)

The report "Newborn Screening Market by Product (Instrument, Consumables), Test Type (Dried Blood Spot, Hearing Screening, CCHD),Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Molecular, Pulse Oximetry),End User (Hospitals) - Global Forecast to 2026" The global newborn screening market size is projected to reach USD 1.3 billion by 2026 from USD 0.9 billion in 2021, at a CAGR of 8.3%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=141676244&utm_source=OPenpr&utm_medium=referral

Growth in this market is driven mainly by the grwoing awareness regarding early diagnosis of diseases in newborn, rising newborn screen rate, favourable government policies to conduct newborn screening.

The consumables segment accounted for the largest share of the newborn screening market in 2019.

Based on the product, the newborn screening market is segmented into consumables and instruments. The consumables further segmented into Assay kits & reagents and other consumables such as newborn screening cards and columns. In 2019, consumables accounted for the largest share of the newborn screening market. The large share of this market segment is mainly due to the constant requirement for consumables in newborn screening. The increasing newborn screening rate across the globe also fuels the demand for consumables.

Browse 166 market data Tables and 37 Figures spread through 177 Pages and in-depth TOC on "Newborn Screening Market by Product (Instrument, Consumables), Test Type (Dried Blood Spot, Hearing Screening, CCHD),Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Molecular, Pulse Oximetry),End User (Hospitals) - Global Forecast to 2026"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/newborn-screening-market-141676244.html?utm_source=OPenpr&utm_medium=referral

The dry blood spot tests segment accounted for the largest share of the newborn screening market in 2019.

The newborn screening market, by test, is segmented into dry blood spot tests, hearing screening tests, and critical congenital heart defect (CCHD) screening tests. In 2019, the dry blood spot tests segment accounted for the largest share of the newborn screening market due to the wide acceptance of dry blood spot tests for screening disorders. Most metabolic, hormonal, and genetic disorders are diagnosed using dry blood spot tests.

North America accounted for the largest share of the newborn screening market in 2019.

North America accounted for the largest share of the newborn screening market in 2019. The large share of this segment can primarily be attributed to the rising incidence of newborn diseases, the availability of reimbursement for newborn screening test, and the strong presence of industry players in the region.

Some of the major players in the newborn screening market include Some of the leading players in the newborn screening market are PerkinElmer (US), Demant A/S (Denmark), Natus Medical (US), Bio-Rad Laboratories (US), Danaher Corporation (US), and Medtronic (Ireland). Others include Chromsystems Instruments & Chemicals GmbH (Germany), Trivitron Healthcare (India), Baebies (US), Parseq Lab (Russia), and Recipe Chemicals+Instruments (Germany).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=141676244&utm_source=OPenpr&utm_medium=referral

Don't miss out on business opportunities in Newborn Screening Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.